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Abstract
Aims Type 2 diabetes (T2D) is known to be associated with high BMI and waist circumference (WC). These measures do 
not discriminate well between skeletal muscle (SM) and body fat (BF), which may have opposite influences.
Methods We conducted a secondary analysis of population-based data from 58,128 aged 18–85 yrs from Scottish Health 
Surveys (2003, 2008–2011) and Health Surveys for England (2003–2006, 2008–2013), excluding pregnant women and insu-
lin-treated diabetes. Logistic regression was used to assess associations of known T2D, and of screened HbA1c > 48 mmol/
mol (> 6.5%), with sex-specific quintiles of BMI, WC, and BF% and SM% estimated by validated anthropometric equations, 
adjusted for age, sex, smoking, ethnicity, country, and survey year.
Results As expected, ORs for having known T2D rose with quintiles of BMI (1, 1.5, 2.3, 3.1, and 6.5) and WC (1, 1.8, 2.5, 
3.5, and 8.7). Compared to the lowest BF% quintile, OR for having T2D in highest BF% quintile was 11.1 (95% CI = 8.4–
14.6). Compared to the highest SM% quintile, OR for having T2D in lowest SM% quintile was 2.0 (1.7–2.4). Of 72 adults 
with T2D/HbA1c > 6.5% in the lowest quintile of BF%, 27 (37.5%) were in quintile 1 of SM%. Similar patterns of OR were 
observed for having HbA1c > 6.5% in those without known T2D.
Conclusions Estimated BF% associates strongly with T2D. Low SM% also has a significant association, suggesting a 
neglected aspect of aetiology within T2D. These two simple measures with biological relevance, available from data col-
lected in most health surveys, may be more useful than the purely statistical terms BMI.
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Introduction
Type 2 diabetes (T2D) is known to be associated with a 
number of anthropometric indices of adiposity including 
body mass index (BMI), waist circumference (WC), and 
waist-to-hip ratio [1]. It is generally accepted that increased 
adiposity is causal in people who are (epi-)genetically pre-
disposed to metabolic syndrome, but T2D can occur in peo-
ple of normal BMI. While extreme BMI, e.g., > 35 kg/m2, 
always indicates excess body fat, but does not relate to spe-
cific body compartments; therefore, this index should not be 
applied to individuals, while its use in general populations 
can be misleading [2–5]. WC is an alternative which is more 
specifically associated with total body and distribution of 
body fat than BMI [6]. In most studies [7, 8], but not all [9, 
10], WC has been shown to have somewhat stronger associa-
tion than BMI with the development of T2D and other car-
diometabolic disorders. In contrast, hips circumference (HC) 
has an inverse relationship with metabolic diseases [11]. A 
Managed by Massimo Porta.
 * T. S. Han 
 thang.han@rhul.ac.uk
 * M. E. J. Lean 
 mike.lean@glagow.ac.uk
1 Institute of Cardiovascular Research, Royal Holloway, 
University of London, Egham, UK
2 Department of Diabetes and Endocrinology, Ashford and St 
Peter’s NHS Foundation Trust, Chertsey, UK
3 Department of Nutrition, School of Medicine, University 
of Glasgow, Glasgow, UK
4 Department of Clinical Nutrition, Imam Abdulrahman bin 
Faisal University, Dammam, Saudi Arabia
5 Health Economics and Health Technology Assessment, 
Institute of Health and Wellbeing, University of Glasgow, 
Glasgow, UK
 Acta Diabetologica
1 3
large HC may be protective, because it reflects a greater 
insulin-sensitive gluteo-femoral muscle mass, while smaller 
HC may indicate gluteo-femoral muscle atrophy [12].
In principle, increased body fat is likely to promote T2D 
by impairing insulin sensitivity, and possibly insulin secre-
tion, particularly when there is ectopic fat in the liver, mus-
cle, and pancreas [13]. However, the main organ for glucose 
disposal, and fat oxidation, is skeletal muscle, so decreased 
muscle mass might also be expected to promote T2D, and 
conditions with muscle loss or atrophy do exhibit impaired 
glucose tolerance [14].
Accurate measurement of body composition requires 
complex methods that are not practically applicable in large 
surveys. Some indirect field methods such as bioelectrical 
impedance have been used in large studies, but they gain 
little or no advantage over anthropometry, when compared 
against reference methods such as magnetic resonance imag-
ing (MRI) [15]. Most epidemiological studies of metabolic 
disorders use BMI, for gauging body composition, but BMI 
does not discriminate well between skeletal muscle (SM) 
and body fat (BF), which may have opposite influences on 
T2D development.
The present study explores the associations of T2D and 
glycated haemoglobin (HbA1c) with BF and SM calculated 
from equations validated against MRI, in a large database of 
national health surveys.
Subjects/methods
Study design, patients, and setting
This analysis utilized cross-sectional data from the Scot-
tish Health Survey (SHS) collected in 2003 and 2008–2011 
(n = 92,216) and Health Survey for England (HSE) collected 
in 2003–2006 and 2008–2013 (n = 140,627). The surveys 
followed identical methods. Subjects younger than 18 years 
or over 85 years were excluded, because they were outside 
the age range of populations used to derive the equations for 
estimating BF and SM. Pregnant women and patients with 
insulin-treated diabetes were also excluded, leaving 58,128 
(26,292 men and 31,836 women) with complete data for 
anthropometric, BF, SM, and T2D, and 38,349 with HbA1c 
screened in individuals without a previous diagnosis of T2D 
(Fig. 1).
Anthropometry
Participants were visited at home by trained nurses who 
recorded demographic information including age, sex, 
ethnicity, smoking status, medical history, and treatment 
by standard health and lifestyle questionnaires. Smoking 
status was reported in categories (never smoked, used to 
smoke occasionally, used to smoke regularly, and cur-
rent smoker). The trained nurses also measured weight, 
height, and waist and hip circumferences by calibrated 
instruments. Participants were asked to wear light cloth-
ing and stand straight in a relaxed position, feet 25–30 cm 
apart. WC was measured midway between the iliac crest 
and lowest rib, and HC at the largest circumference around 
the buttocks.
Body fat and skeletal muscle calculations
Percentage body fat was calculated using validated pub-
lished equations for men: BF% = 0.567 × WC (cm) + 0.101 
× age (years)−31.8 and for women: BF% = 0.439 × 
WC (cm) + 0.221 × age (years)−9.4 [2]. SM was cal-
culated using published validated equations for men: 
SM (kg) = 39.5 + 0.665 × body weight (kg)−0.185 WC 
(cm)−0.418 × HC−0.08 × age (years), and for women: SM 
(kg) = 2.89 + 0.255 × weight (kg)−0.175 × HC (cm)−0.038 
× age (years) + 0.118 × height (cm) [16]. SM was expressed 
as percent body weight for analysis.
Outcome variables
HbA1c was measured using non-fasting blood samples. Dia-
betes mellitus, assumed to be T2D as insulin-treated sub-
jects were excluded, was identified first from participants 
reporting that the diagnosis had been confirmed by a doctor 
or a nurse, or secondly as newly diagnosed on the basis of 
having HbA1c > 48 mmol/mol (> 6.5%) without previously 
diagnosed T2D.
Total:
n=58128
Known T2D: 
n=2575/58128 (4.4%)
HbA1c screen in non-
diabec subjects: n=38349
HbA1c >6.5%: 
n=607/38349 (1.6%)
Known T2D + Newly diagnosed DM:
n=3182/40924 (7.8%)
Fig. 1  Flowchart showing the numbers of subjects available for anal-
ysis in the present study
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Statistical analysis
Group differences were assessed by independent t test for 
continuous variables and by chi-squared test for categori-
cal variables. The associations of T2D or HbA1c > 6.5% 
(dependent variables) with BMI, WC, BF, and SM (inde-
pendent variables) were assessed by logistic regression 
analysis to estimate odds ratios (ORs) and 95% confidence 
intervals (CIs). Independent variables were categorised into 
quintiles. Data were adjusted for age, sex, smoking status 
(categorised into non-smokers and current or ex-smokers), 
ethnicity (categorised into white Caucasians or others), 
survey year, and country. Analyses were conducted using 
SPSS (version 23.0). The null hypothesis was rejected when 
P < 0.05.
Results
Men and women had similar mean (± SD) age 
(50.2 years ± 18.8 v.s. 49.3 years, ± 18.7), BMI (27.8 kg/
m2 ± 4.5 v.s. 27.3 kg/m2, ± 5.6), and HC (103.9 cm ± 10.4 
v.s. 103.8 cm ± 10.1). Men were taller (174.6 cm ± 7.2 v.s. 
161.2 cm ± 6.8, P < 0.001) and heavier (84.1 kg ± 14.9 
v.s. 70.8  cm ± 14.9, P < 0.001), and had larger WC 
(98.1  cm ± 12.2 v.s. 87.6  cm ± 13.2, P < 0.001), SM 
(29.8 kg ± 6.2 v.s. 19.9 kg, ± 3.0, P < 0.001), and SM% 
(35.6% of body weight ± 5.4 v.s. 28.7% of body weight, 
± 4.3, P < 0.001), while women had higher BF than men 
(29.1 kg ± 11.5 v.s. 25.1 kg, ± 8.3, P < 0.001) and BF% 
(40.0% of body weight ± 7.6 v.s. 28.9% of body weight, 
± 7.7, P < 0.001).
Table 1 shows distribution of demographic factors and 
prevalences of T2D and of HbA1c > 6.5%. The prevalence 
of T2D increased with age, and it was higher in men than 
in women, in current and ex-smokers than in non-smokers, 
in ethnic minorities than in white Caucasians, and in Scot-
land than in England.
Tables 2 and 3 show that adjusted ORs for having T2D 
increased with increasing sex-specific quintiles of BMI, 
WC, and BF%, and with decreasing SM% (decreasing 
muscularity). Prevalences of T2D within quintiles of BF% 
were 0.5, 1.4, 2.6, 5.1, and 12.5% and conversely within 
quintiles of SM% were 10.1, 5.3, 3.0, 1.9, and 1.8%. Com-
pared with the lowest BMI or WC quintile, OR for having 
T2D in the highest BMI quintile was 6.5 (5.5–7.8) and in 
the highest WC quintile was 8.7 (7.0–10.7). Compared 
to the lowest BF% quintile, OR for having T2D in high-
est BF% quintile was 11.1 (95% CI = 8.4–14.6). BF% was 
associated with T2D more strongly than either BMI or 
WC throughout all ranges of BMI including among those 
with BMI < 25 kg/m2. Compared to the highest SM% quin-
tile, OR for having T2D in lowest SM% quintile was 2.0 
(1.7–2.4). Of 72 adults with T2D/HbA1c > 6.5% in the 
lowest quintile of BF%, 27 (37.5%) were in quintile 1 of 
SM%.
Very similar BF% and SM% quintile patterns were 
observed for prevalences and OR of having HbA1c > 6.5% 
without known T2D (Tables 2, 3).
Further analysis was conducted by combining the indi-
viduals with known T2D and those with HbA1c > 6.5% 
without known diabetes, as the dependent variable. The 
combined prevalence of T2D again rose with higher 
quintiles of BF% (Fig. 2a) and with lower quintiles of 
SM% (Fig. 2b). Compared to individuals in the lowest 
sex-specific quintile of BF%, those in the highest quin-
tile were 12.7-fold (10–16.2) more likely to have either 
diagnosed T2D or HbA1c > 6.5%. Compared to individu-
als in the highest quintile of SM%, those in the lowest 
(A)
(B)
Fig. 2  Distribution and ORs (adjusted for age, sex, smoking, ethnic-
ity, survey year, and country) for having T2D and/or HbA1c > 6.5% 
in different sex-specific quintiles of BF% (a) or SM% (b) in 40,924 
subjects
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quintile were 2.3-fold (2.0–2.7) more likely to have T2D 
or HbA1c > 6.5%. Among the 3182 of individuals with any 
T2D (known or new) in the lowest quintile of BF% (72), 3 
(4.2%) were in the lowest quintile of SM%.
Discussion
The present study applied published, validated, equations 
based on data routinely collected in most large national 
health surveys to estimate BF% and SM%. We confirmed the 
known associations of BMI and WC with HbA1c and T2D. 
We observed a stronger relationship between BF% and T2D, 
and also a significant inverse relationship between SM% and 
T2D. While causal relationships cannot be proved in cross-
sectional studies, the enormously powerful, well-established 
relationship of adiposity with T2D is already accepted as its 
main causal factor. Weight gain which exceeds the variable 
‘personal fat threshold’ reveals a predisposition, most likely 
epigenetic, for metabolic syndrome and T2D with ectopic 
(liver and pancreas) fat accumulation [13]. The inverse rela-
tionship with SM% may provide further insights into the 
aetiology of T2D, supporting the notion that muscle is gen-
erally protective against metabolic syndrome and T2D. This 
would potentially explain the protective association of high 
hip circumference (from gluteal muscle) [11, 12].
There was also evidence of significant associations of 
T2D and HbA1C > 6.5% with both low SM% and high BF%, 
but this combination does not always co-exist within indi-
viduals. This suggests that these two measures detect differ-
ent individuals with T2D, which could point towards T2D 
being promoted by different body-composition phenotypes, 
potentially demanding different approaches to treatment and 
prevention.
High BF%, particularly intra-abdominal adipose tissue, 
may have a key intermediary role in the development of 
insulin resistance and subsequent T2D. It is now recognised 
that intra-abdominal fat is an active endocrine organ produc-
ing a number of adipocytokines such as adiponectin, leptin, 
resistin, and interleukins, which play a crucial role in appe-
tite and energy regulation [14]. An imbalanced production of 
these factors by an expanded intra-abdominal fat mass prob-
ably contributes to weight-related metabolic disorders [17].
We have previously shown that the prevalence of meta-
bolic syndrome was increased in those with either low BMI 
and high WC, or high BMI and low WC, compared to indi-
viduals who had low BMI and low WC [18]. However, a 
high BMI may be misinterpreted as overweight or even 
obesity among people in training of power sports such as 
American football players or heavyweight boxers, where a 
high BMI reflects a high SM mass [19]. This is the reason 
for the use of the diametrically opposed measurements of 
Table 1  Distribution of T2D and HbA1c > 6.5% among demographic factors
T2D (n = 2575) HbA1c > 6.5% without known T2D (n = 607)
n (% of study cohort) Prevalence (%) Chi-square test n (% of study cohort) Prevalence (%) Chi-square test
Age (years)
 18–29 8574 (1.8%) 0.4% < 0.001 5097 (13.3%) 0.2% < 0.001
 30–39 10,428 (17.9%) 0.9% 6885 (18.0%) 0.3%
 40–49 11,408 (19.6%) 2.2% 7913 (20.6%) 0.9%
 50–59 10,565 (18.2%) 4.7% 7216 (18.8%) 2.0%
 60–69 9621 (16.6%) 8.7% 6509 (17.0%) 2.8%
 70–79 6067 (10.4%) 12.0% 3859 (10.1%) 3.8%
 80–85 1465 (2.5%) 9.2% 870 (2.3%) 3.7%
Sex
 Men 26,292 (45.2%) 5.5% < 0.001 17,425 (45.4%) 1.9% < 0.001
 Women 31,836 (58.8%) 3.6% 20,924 (54.6%) 1.3%
Smoking status
 Non-smokers 15,959 (27.5%) 3.6% < 0.001 10,567 (27.6%) 1.5% 0.139
 Current and ex-smokers 42,124 (72.5%) 4.7% 27,759 (72.4%) 1.6%
Ethnicity
 White Caucasians 50,106 (86.2%) 4.2% < 0.001 33,439 (87.4%) 1.5% 0.001
 Others 8022 (13.8%) 5.8% 4910 (12.8%) 2.1%
Country
 England 48,760 (83.9%) 4.2% < 0.001 31,442 (82.0%) 1.5% 0.043
 Scotland 9368 (16.1%) 5.6% 6907 (18.0%) 1.8%
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FM% and SM% herein to improve discrimination between 
fat and muscle components.
The significant association of HbA1c and T2D with low 
SM% demonstrated here has not been well documented in 
the literature. In a cross-sectional study of Koreans, SM was 
2–4-fold lower in individuals with T2D than those without 
[20] and an NHANES study found inverse associations of 
insulin resistance index (HOMA-IR) and pre-diabetes (based 
on HbA1c) with a ‘skeletal muscle index’ derived from bio-
electrical impedance, adjusted for age, sex, ethnicity, and 
adiposity [21]. It is not possible to define the mechanisms, 
or even direction of causality, between SM% and HbA1c or 
T2D, likely involving multiple factors. SM commonly falls 
during the clinical presentation of T2D as a direct result 
of diminished insulin activity [22], but it is also the main 
oxidative organ and site of glucose disposal. Low SM% by 
mass is likely to be a very crude correlate of the whole-body 
metabolic functions of different muscle components. T2D 
has been associated with a relative paucity of type 1 (oxida-
tive) muscle fibres, and excess of type 2 muscle fibres [23]. 
Muscle mass may be low or reduced for genetic reasons, 
and by inflammatory diseases as well as malnutrition. An 
association between impaired glucose tolerance and T2D 
with low SM has been shown previously in conditions with 
primary muscle loss or atrophy, such as immobility [24], 
muscular dystrophies, myopathies [25], cancer [26], or 
stroke [27], while low SM has also been shown to associate 
with hypertension [28].
There are certain limitations to the present study, 
including the cross-sectional design, but that should not 
diminish the validity of the new analysis for BF% and 
SM%, particularly as the analyses for BMI and WC are in 
line with published data. The previous studies have shown 
slightly variable associations, e.g., stronger associations 
with WC and incidence of T2D in long term follow-up 
studies [29], than in cross-sectional studies where WHR 
tends to be more powerful. The present study adds sup-
port to the view that small hip circumference (thus higher 
waist:hip ratio) is predictive, because it may reflect 
reduced gluteal muscle mass. The equations for calculating 
BF% and SM% were derived in studies of predominantly 
Caucasian adults, but with few elderly individuals [2, 16]. 
The HSE and SHS databases used in the present study 
also comprise mostly Caucasians (86.2%), so the anthro-
pometric equations are likely to be appropriate for their 
body compositions. Estimates of BF% or SM% in older 
people, or with different ethnic backgrounds, may be less 
accurate and different equations may be needed. Equations 
used to estimate SM include HC as one of the variables 
may be less accurate in older adults and in females due to 
their higher proportion of adipose tissue for a given HC. 
Our study, therefore, excluded subjects over 85 years old. 
However, the inclusion of this oldest age group did not Ta
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substantially change our findings. The survey base was 
large, and surveys are typical representative national sur-
veys, but study power was reduced, because not all the 
measures were made for every subject in every year.
The use of existing survey data is economical, but has 
drawbacks, because the number of collected variables is 
fixed and may limit analyses. For example, we did not have 
information on the duration of diabetes, but we did attempt 
to reduce associated errors by excluding insulin-treated 
patients (likely to have longer duration of diabetes). Meas-
urement errors are always possible. Accuracy is important 
at individual level to avoid misclassification of subjects in 
categories of interest such as BMI, but the sizes of errors in 
measuring height, weight, or waist circumference are not 
great enough to cause frequent misclassification, which is 
more severely affected in self-reported than in measured 
data [30]. When analysing large national surveys to estab-
lish associations, as in the present study, minor measure-
ment errors are unlikely to be problematic, since the large 
study number allows confidence in the findings. The lack of 
information on oral antihyperglycaemic agents is another 
limitation, but the patterns of associations between body 
composition with T2D and body composition with HbA1c 
are similar, suggesting a valid observation. Another common 
drawback with surveys is bias in participation, which may 
explain the relatively low prevalence of T2D in this present 
study, e.g., high proportion of younger adults (with low rates 
of T2D) and recruiting a low proportion of those with T2D 
because of health problems and hospital appointments, etc. 
Excluding those treated with insulin for the present analysis 
would also have lowered the apparent rates of T2D.
In conclusion, estimated BF% associates with T2D. 
Low SM% is also a significant factor. These two simple 
measures, available from data collected in most health 
surveys, may be more useful than using BMI or WC for 
assessing T2D. These results suggest two distinct body-
composition phenotypes driving type-2 diabetes, with 
implications for prevention and treatment strategies. Fur-
ther exploration would be valuable, especially confirma-
tion in longitudinal follow-up studies.
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